Airway goblet-cell mucus secretion

被引:62
作者
Jackson, AD [1 ]
机构
[1] Novartis Horsham Res Ctr, Horsham RH12 5AB, W Sussex, England
关键词
D O I
10.1016/S0165-6147(00)01600-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A mucus hypersecretory phenotype is a dominant characteristic of chronic airways diseases such as chronic bronchitis and asthma. This phenotype develops following chronic exposure of the respiratory tract to particulate matter, allergens, irritants and/or pathogens. The associated increase in the mucus-producing potential of the respiratory epithelium represents an innate host response that can be modulated by elements of the adaptive host response. Although elevation of mucus production is designed to protect the airways, increasing evidence suggests that in excess it can be detrimental to health. Considerable progress has been made over the past five years in understanding the mechanisms involved in the development and regulation of the hypersecretory phenotype. This progress has set the stage for the development of successful dedicated mucomodulatory strategies to counter the negative impact of excess mucus production in respiratory disease.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 41 条
[1]   Goblet cell degranulation after antigen challenge in sensitized guinea pigs - Role of neutrophils [J].
Agusti, C ;
Takeyama, K ;
Cardell, LO ;
Ueki, I ;
Lausier, J ;
Lou, YP ;
Nadel, JA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (04) :1253-1258
[2]   MARKED GOBLET CELL HYPERPLASIA WITH MUCUS ACCUMULATION IN THE AIRWAYS OF PATIENTS WHO DIED OF SEVERE ACUTE ASTHMA ATTACK [J].
AIKAWA, T ;
SHIMURA, S ;
SASAKI, H ;
EBINA, M ;
TAKISHIMA, T .
CHEST, 1992, 101 (04) :916-921
[3]   MORPHOMETRIC ANALYSIS OF INTRALUMINAL MUCUS IN AIRWAYS IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
AIKAWA, T ;
SHIMURA, S ;
SASAKI, H ;
TAKISHIMA, T ;
YAEGASHI, H ;
TAKAHASHI, T .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (02) :477-482
[4]  
Barnes PJ, 2000, CHEST, V117, P63
[5]   Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing toll-like receptors [J].
Cario, E ;
Rosenberg, IM ;
Brandwein, SL ;
Beck, PL ;
Reinecker, HC ;
Podolsky, DK .
JOURNAL OF IMMUNOLOGY, 2000, 164 (02) :966-972
[6]   T helper 1 cells and interferon γ regulate allergic airway inflammation and mucus production [J].
Cohn, L ;
Homer, RJ ;
Niu, NQ ;
Bottomly, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (09) :1309-1317
[7]  
Dabbagh K, 1999, J IMMUNOL, V162, P6233
[8]   Purines and neutrophil leukocytes [J].
Fredholm, BB .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1997, 28 (03) :345-350
[9]  
Graul A., 2000, Drugs of the Future, V25, P165, DOI 10.1358/dof.2000.025.02.567187
[10]   Requirement for IL-13 independently of IL-4 in experimental asthma [J].
Grünig, G ;
Warnock, M ;
Wakil, AE ;
Venkayya, R ;
Brombacher, F ;
Rennick, DM ;
Sheppard, D ;
Mohrs, M ;
Donaldson, DD ;
Locksley, RM ;
Corry, DB .
SCIENCE, 1998, 282 (5397) :2261-2263